4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > ligase > immusmol/Glutamate ELISA试剂盒-研究/BA-E-2400
商品详细immusmol/Glutamate ELISA试剂盒-研究/BA-E-2400
immusmol/Glutamate ELISA试剂盒-研究/BA-E-2400
immusmol/Glutamate ELISA试剂盒-研究/BA-E-2400
商品编号: BA-E-2400
品牌: immusmol
市场价: ¥7600.00
美元价: 3800.00
产地: 美国(厂家直采)
公司:
产品分类: 连接酶
公司分类: ligase
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Product informationKey stepsReferencesTechnical supportReviews

Product overview

Product name

L-Glutamate ELISA kit - Research

DescriptionEnzyme immunoassay (ELISA) for the quantitative determination of L-Glutamic acid in biological samples. Research use only.
Format96-well plate
SamplesAny sample
Sample volume100 µl
Cross specie-reactivityReact with all species
Standard range0 / 0.6 - 60 µg/ml
Sensitivity

0.3 µg/ml

SpecificityNo significant cross-reactivity was observed with L-Glutamate analogs such as Glutamine, Aspartate, Glycine, Alanine and 5-aminovaleric acid.
Assay time2h30 sample extraction and derivatization, ELISA overnight
StorageStore at 2-8°C for to 6 months.
DatasheetsInstructions for useMaterial safety datasheet
Top

Key steps

Sample preparation

Sample extraction and derivatization (2h30)

ELISAGlutamate antiserum overnight incubation, revelation and read steps (1h).
Detailed protocolDownload instructions for use
Top

References

  • Warren DE et al. Hypothermia and rewarming injury in hippocampal neurons involve intracellular Ca2+ and glutamate excitotoxicity. Neuroscience. 2012 Apr 5;207:316-25.
Top

Technical SupportSubmit a question

No technical question yet. Be the first to ask!Top

ReviewsSubmit your review

No reviews yet. Thanks for rating this product.Top
品牌介绍
我们的重点:针对小分子的抗体ImmuSmol代表“针对小分子的免疫球蛋白[抗体]”。传统抗体只能识别蛋白质等大分子,而ImmuSmol设计并开发能够靶向低分子量实体(<900 Da)的抗体。因此,氨基酸,脂质,糖类,毒素,药物……实际上,任何小分子都可以以高亲和力和特异性来处理。与现有的基于抗体的技术完全兼容,小分子抗体为研究,诊断和治疗开辟了全新的可能性。三大核心应用研究抗体 -ImmuSmol销售经过验证的 一抗,用于细胞和组织中的小分子检测和可视化。定制服务 -ImmuSmol提供针对小分子的抗体,用于研究,诊断和治疗应用。诊断与治疗 -目前正在开发基于专有小分子抗体的三种个性化医学程序。